X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (169) 169
Book / eBook (7) 7
Patent (6) 6
Publication (5) 5
Conference Proceeding (2) 2
Book Chapter (1) 1
Book Review (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (78) 78
female (61) 61
male (60) 60
middle aged (59) 59
index medicus (50) 50
liver transplantation (50) 50
gastroenterology & hepatology (42) 42
aged (41) 41
transplantation (34) 34
adult (30) 30
surgery (28) 28
recurrence (22) 22
retrospective studies (22) 22
treatment outcome (22) 22
hepatitis c (19) 19
cirrhosis (18) 18
liver (17) 17
patients (16) 16
prognosis (16) 16
ribavirin (16) 16
antiviral agents - therapeutic use (15) 15
prospective studies (15) 15
follow-up studies (14) 14
hepatitis (14) 14
survival (14) 14
liver transplantation - adverse effects (13) 13
analysis (12) 12
efficacy (12) 12
aged, 80 and over (11) 11
disease (11) 11
hepacivirus - genetics (11) 11
hepatocellular carcinoma (11) 11
interferon (11) 11
spain (11) 11
allografts (10) 10
drug therapy, combination (10) 10
gastroenterology and hepatology (10) 10
hepatitis c, chronic - drug therapy (10) 10
immunosuppression (10) 10
recipients (10) 10
therapy (10) 10
time factors (10) 10
antiviral agents - administration & dosage (9) 9
cancer (9) 9
hcv (9) 9
hepatitis c virus (9) 9
safety (9) 9
syngeneic grafts (9) 9
transplants & implants (9) 9
drug therapy (8) 8
health aspects (8) 8
hepatitis c - drug therapy (8) 8
hepatitis c - virology (8) 8
hepatocellular-carcinoma (8) 8
infections (8) 8
liver diseases (8) 8
liver neoplasms - surgery (8) 8
liver transplant (8) 8
risk factors (8) 8
antiviral therapy (7) 7
antiviral treatment (7) 7
infection (7) 7
liver cirrhosis - complications (7) 7
liver transplantation - mortality (7) 7
mortality (7) 7
multivariate analysis (7) 7
organ transplant recipients (7) 7
predictive value of tests (7) 7
severity of illness index (7) 7
survival analysis (7) 7
survival rate (7) 7
antiviral agents - adverse effects (6) 6
carcinoma, hepatocellular - surgery (6) 6
direct-acting antivirals (6) 6
hcv infection (6) 6
infectious diseases (6) 6
liver cirrhosis (6) 6
liver cirrhosis - surgery (6) 6
management (6) 6
medical research (6) 6
natural-history (6) 6
prevalence (6) 6
prophylaxis (6) 6
registries (6) 6
ribavirin - therapeutic use (6) 6
sofosbuvir (6) 6
tacrolimus (6) 6
virus-infection (6) 6
biological response modifiers (5) 5
carcinoma, hepatocellular - complications (5) 5
carcinoma, hepatocellular - mortality (5) 5
cohort studies (5) 5
diagnosis (5) 5
diseases (5) 5
genotype (5) 5
genotypes (5) 5
hepatitis c, chronic - surgery (5) 5
hiv infections - complications (5) 5
immunology (5) 5
liver cirrhosis - virology (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e103028
Background: Acute and chronic hepatitis E have been associated with high mortality and development of cirrhosis, particularly in solid-organ recipients and... 
ANTIBODIES | IGG SEROPREVALENCE | SOUTHWEST ENGLAND | TRANSFUSION | MULTIDISCIPLINARY SCIENCES | HEV | BLOOD-DONORS | PREVALENCE | RIBAVIRIN | RECIPIENTS | SPAIN | Cross-Sectional Studies | Immunoglobulin G - blood | Liver Transplantation - adverse effects | Liver Cirrhosis - complications | Humans | Middle Aged | Risk Factors | Male | Seroepidemiologic Studies | Hepatitis E - epidemiology | Hepatitis E virus - immunology | Immunoglobulin G - immunology | Spain - epidemiology | Hepatitis Antibodies - blood | Hepatitis Antibodies - immunology | HIV Infections - complications | Adult | Female | Aged | Hepatitis E - etiology | Immunocompromised Host | Hepatitis E | Kidneys | Immunoglobulin G | Mortality | Organ transplant recipients | HIV patients | Transplantation | HIV (Viruses) | Risk factors | Hepatitis C virus | Health aspects | HIV infection | Liver cirrhosis | Health care | Transplants & implants | Liver | Chronic infection | Viruses | Infections | Statistical methods | Biochemistry | Multivariate analysis | Epidemiology | Hepatitis | Human immunodeficiency virus--HIV | Immunoglobulins | Departments | Liver diseases | Statistical analysis | Blood & organ donations | Internal medicine | Test procedures | Health risks | Risk analysis | Patients | Disease control | Virology | Medicine | Pathology | Cirrhosis | Hospitals | Liver transplantation | Kidney transplantation | HIV | Human immunodeficiency virus
Journal Article
Studies in Higher Education, ISSN 0307-5079, 11/2019, Volume 44, Issue 11, pp. 1874 - 1888
This article looks at an experience within the context of distance higher education, which has incorporated the reading of two novelettes (short novels,... 
Novelette | learning | criminology | narrative | transportation | Instructional Materials | Higher Education | Distance Education | Instructional Effectiveness | Student Attitudes | Novels | Teaching Methods | Foreign Countries | Open Universities | Criminology | Learning | Novellas
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 09/2019, Volume 9, Issue 1, pp. 1 - 16
Although it is specific for prostatic tissue, serum prostate-specific antigen (PSA) screening has resulted in an over-diagnosis of prostate cancer (PCa) and... 
MIGRATION | MECHANISM | FLUID | MULTIDISCIPLINARY SCIENCES | PROSTASOMES | PROLIFERATION | MICRORNAS | EXPRESSION | CARCINOMA | MIR-342-3P | ANTIGEN | Prognosis | Molecular modelling | Prostate-specific antigen | Semen | Invasiveness | Biomarkers | miRNA | Diagnosis | Exosomes | Prostate cancer | Tumors
Journal Article
Medicina Clinica, ISSN 0025-7753, 05/2009, Volume 132, Issue 18, p. 726
Journal Article
Medicina Clinica, ISSN 0025-7753, 03/2009, Volume 132, Issue 9, pp. 348 - 350
Journal Article
Liver Transplantation, ISSN 1527-6465, 04/2016, Volume 22, Issue 4, pp. 446 - 458
Daclatasvir (DCV) is a potent, pangenotypic nonstructural protein 5A inhibitor with demonstrated antiviral efficacy when combined with sofosbuvir (SOF) or... 
SURGERY | INTERFERON-ALPHA-2B | ANTIVIRAL THERAPY | RIBAVIRIN | COMBINATION | VIROLOGICAL RESPONSE | HCV INFECTION | TRANSPLANTATION | GENOTYPE 1 | PLUS SOFOSBUVIR | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | COMPASSIONATE USE | Recurrence | Liver Transplantation - adverse effects | Compassionate Use Trials | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Male | Hepatitis C, Chronic - complications | Simeprevir - therapeutic use | Simeprevir - adverse effects | Simeprevir - administration & dosage | Ribavirin - administration & dosage | Female | Retrospective Studies | Imidazoles - therapeutic use | Sofosbuvir - adverse effects | Sofosbuvir - therapeutic use | Hepacivirus - isolation & purification | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Ribavirin - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug Therapy, Combination - methods | Sofosbuvir - administration & dosage | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Liver Cirrhosis - pathology | Liver Diseases - surgery | Aged | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
Hepatology, ISSN 0270-9139, 06/2017, Volume 65, Issue 6, pp. 1810 - 1822
Direct‐acting antiviral agents (DAAs) are highly effective and well tolerated in patients with chronic hepatitis C virus infection, including those with... 
SUSTAINED VIROLOGICAL RESPONSE | ACTING ANTIVIRAL THERAPY | ALL-CAUSE MORTALITY | HEPATOCELLULAR-CARCINOMA | PEGYLATED INTERFERON | SIMEPREVIR PLUS SOFOSBUVIR | GENOTYPE 1 INFECTION | HCV | RIBAVIRIN | REDUCES RISK | GASTROENTEROLOGY & HEPATOLOGY | Multivariate Analysis | Predictive Value of Tests | Prognosis | Humans | Middle Aged | Hepatitis C, Chronic - physiopathology | Liver Cirrhosis - mortality | Hepacivirus - genetics | Male | Hepatitis C, Chronic - mortality | Cause of Death | Ribavirin - administration & dosage | Aged, 80 and over | Adult | End Stage Liver Disease - drug therapy | Female | Registries | Retrospective Studies | Hepacivirus - drug effects | Liver Function Tests | Severity of Illness Index | Liver Cirrhosis - drug therapy | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Disease Progression | End Stage Liver Disease - pathology | Spain | End Stage Liver Disease - mortality | Liver Cirrhosis - virology | Sofosbuvir - administration & dosage | Survival Analysis | Aged | Liver Cirrhosis - physiopathology | Cohort Studies | End Stage Liver Disease - virology | Cirrhosis | Antiviral agents | Hepatitis | Liver diseases | Chronic infection | Data processing | Interferon | Hepatitis C | Patients
Journal Article
Transplantation, ISSN 0041-1337, 07/2018, Volume 102 Suppl 7S-1, pp. S124 - S124
BACKGROUNDDue to increased aged population, the number of the worlds people older than 60 years will rise to 2 billion in 2050 and improved health of this... 
Journal Article
Journal of Hepatology, ISSN 0168-8278, 07/2018, Volume 69, Issue 1, p. 11
Background & Aims The efficacy of direct-acting antivirals (DAAs) has dramatically changed the prognosis of patients with chronic hepatitis C. We aimed to... 
Antiviral agents | Effectiveness | Liver diseases | Transplants & implants | Syngeneic grafts | Liver | Mortality | Serology | Survival | Immunosuppressive agents | Hepatitis | Cirrhosis | Allografts | Interferon | Hepatitis C | Antiviral drugs | Liver transplantation
Journal Article
Journal of Hepatology, ISSN 0168-8278, 07/2018, Volume 69, Issue 1, pp. 11 - 17
[Display omitted] •After the approval of DAAs, post-liver transplant survival has significantly increased.•The improved survival of LT recipients is exclusive... 
HCV | Waiting list | Direct-acting antivirals | Liver transplantation | ACTING ANTIVIRAL THERAPY | VIRUS-INFECTION | SOFOSBUVIR | RISK | RECURRENT HEPATITIS-C | SUSTAINED VIROLOGICAL RESPONSE | HEPATOCELLULAR-CARCINOMA | DISEASE | CIRRHOTIC-PATIENTS | PREVENT RECURRENCE | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
by Chen, Qian and Perales, Celia and Soria, María Eugenia and García-Cehic, Damir and Gregori, Josep and Rodríguez-Frías, Francisco and Buti, María and Crespo, Javier and Calleja, José Luis and Tabernero, David and Vila, Marta and Lázaro, Fernando and Rando-Segura, Ariadna and Nieto-Aponte, Leonardo and Llorens-Revull, Meritxell and Cortese, Maria Francesca and Fernandez-Alonso, Irati and Castellote, José and Niubó, Jordi and Imaz, Arkaitz and Xiol, Xavier and Castells, Lluís and Riveiro-Barciela, Mar and Llaneras, Jordi and Navarro, Jordi and Vargas-Blasco, Víctor and Augustin, Salvador and Conde, Isabel and Rubín, Ángel and Prieto, Martín and Torras, Xavier and Margall, Nuria and Forns, Xavier and Mariño, Zoe and Lens, Sabela and Bonacci, Martin and Pérez-del-Pulgar, Sofía and Londoño, Maria Carlota and García-Buey, María Luisa and Sanz-Cameno, Paloma and Morillas, Rosa and Martró, Elisa and Saludes, Verónica and Masnou-Ridaura, Helena and Salmerón, Javier and Quíles, Rosa and Carrión, José Antonio and Forné, Montserrat and Rosinach, Mercè and Fernández, Inmaculada and García-Samaniego, Javier and Madejón, Antonio and Castillo-Grau, Pilar and López-Núñez, Carme and Ferri, María José and Durández, Rosa and Sáez-Royuela, Federico and Diago, Moisés and Gimeno, Concepción and Medina, Rafael and Buenestado, Juan and Bernet, Albert and Turnes, Juan and Trigo-Daporta, Matilde and Hernández-Guerra, Manuel and Delgado-Blanco, Manuel and Cañizares, Angelina and Arenas, Juan Ignacio and Gomez-Alonso, Maria Juana and Rodríguez, Manuel and Deig, Elisabet and Olivé, Gemma and Río, Oscar del and Cabezas, Joaquín and Quiñones, Ildefonso and Roget, Mercè and Montoliu, Silvia and García-Costa, Juan and Force, Lluís and Blanch, Silvia and Miralbés, Miguel and López-de-Goicoechea, María José and García-Flores, Angels and Saumoy, María and Casanovas, Teresa and Baliellas, Carme and Gilabert, Pau and Martin-Cardona, Albert and Roca, Rosa and Barenys, Mercè and Villaverde, Joana and Salord, Silvia and Camps, Blau and Silvan di Yacovo, María and Ocaña, Imma and Sauleda, Silvia and Bes, Marta and Carbonell, Judit and Vargas-Accarino, Elena and Ruzo, Sofía P and ...
Antiviral Research, ISSN 0166-3542, 02/2020, Volume 174, p. 104694
A percentage of hepatitis C virus (HCV)-infected patients fail direct acting antiviral (DAA)-based treatment regimens, often because of drug... 
HCV | NGS | Antiviral treatment | RAS | Failure | Direct-acting antivirals
Journal Article